Entera Bio Ltd. SEC filings ENTX

Entera Bio Ltd. has 418 filings in SEC EDGAR's recent list, going back to May 1, 2015. Its latest annual report, Form ARS, was filed on Jun 3, 2026 for the period ended Jun 3, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.

Entera Bio Ltd. SEC filings
Form Description Filed Period
SCHEDULE 13G Ownership over 5% (passive) Oct 30, 2026 —
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 27, 2026 Oct 27, 2026
DEF 14A Proxy statement Oct 14, 2026 Oct 14, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 6, 2026 Oct 6, 2026
PRE 14A Preliminary proxy statement Sep 23, 2026 Sep 23, 2026
EFFECT Filing Aug 28, 2026 —
424B3 Prospectus Aug 28, 2026 —
S-3 Shelf registration Aug 21, 2026 —
3 Initial insider ownership Aug 21, 2026 Aug 18, 2026
8-K Current report
Regulation FD disclosure, Other events
Aug 18, 2026 Aug 18, 2026
D Filing Aug 12, 2026 —
4 Insider transaction Aug 7, 2026 Aug 7, 2026
4 Insider transaction Aug 7, 2026 Aug 7, 2026
4 Insider transaction Aug 7, 2026 Aug 7, 2026
4 Insider transaction Aug 7, 2026 Aug 7, 2026
4 Insider transaction Aug 7, 2026 Aug 7, 2026
4 Insider transaction Aug 7, 2026 Aug 7, 2026
4 Insider transaction Aug 7, 2026 Aug 7, 2026
4 Insider transaction Aug 7, 2026 Aug 7, 2026
4 Insider transaction Aug 7, 2026 Aug 7, 2026
S-8 Employee stock plan registration Aug 7, 2026 —
10-Q Quarterly report Aug 7, 2026 Jun 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Aug 7, 2026 Aug 7, 2026
SCHEDULE 13G Ownership over 5% (passive) Aug 4, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 4, 2026 —
SCHEDULE 13D Ownership over 5% (active) Aug 4, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 4, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 4, 2026 —
8-K Current report
Material agreement, Unregistered share sale, Officer or director change
Jul 28, 2026 Jul 26, 2026
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Jul 16, 2026 Jul 14, 2026
4 Insider transaction Jul 16, 2026 Jul 14, 2026
DEFA14A Additional proxy material Jun 3, 2026 —
ARS Annual report to shareholders Jun 3, 2026 Jun 3, 2026
DEF 14A Proxy statement Jun 3, 2026 Jun 3, 2026
EFFECT Filing May 15, 2026 —
424B3 Prospectus May 15, 2026 —
PRE 14A Preliminary proxy statement May 14, 2026 May 14, 2026
CORRESP Letter to the SEC May 13, 2026 —
UPLOAD Letter from the SEC May 12, 2026 —
4 Insider transaction May 8, 2026 May 7, 2026
4 Insider transaction May 8, 2026 May 7, 2026
4 Insider transaction May 8, 2026 May 7, 2026
S-3 Shelf registration May 8, 2026 —
10-Q Quarterly report May 8, 2026 Mar 31, 2026
8-K Current report
Results of operations, Regulation FD disclosure
May 8, 2026 May 8, 2026
8-K Current report
Material agreement, Unregistered share sale
Apr 3, 2026 Apr 1, 2026
10-K Annual report Mar 27, 2026 Dec 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Mar 27, 2026 Mar 27, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
8-K Current report
Regulation FD disclosure
Mar 4, 2026 Mar 4, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 11, 2026 Feb 10, 2026
4 Insider transaction Feb 11, 2026 Feb 10, 2026
4 Insider transaction Feb 11, 2026 Feb 9, 2026
4 Insider transaction Feb 11, 2026 Feb 9, 2026
3 Initial insider ownership Feb 9, 2026 Feb 4, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Feb 9, 2026 Feb 4, 2026
3 Initial insider ownership Feb 5, 2026 Feb 1, 2026
8-K Current report
Material agreement, Officer or director change, Regulation FD disclosure
Feb 4, 2026 Jan 29, 2026
4 Insider transaction Jan 2, 2026 Jan 1, 2026
4 Insider transaction Jan 2, 2026 Jan 1, 2026
4 Insider transaction Jan 2, 2026 Jan 1, 2026
4 Insider transaction Jan 2, 2026 Jan 1, 2026
4 Insider transaction Jan 2, 2026 Jan 1, 2026
4 Insider transaction Dec 30, 2025 Dec 29, 2025
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Nov 14, 2025 Nov 14, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
10-Q Quarterly report Aug 8, 2025 Jun 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Aug 8, 2025 Aug 8, 2025
8-K Current report
Regulation FD disclosure, Other events
Jul 28, 2025 Jul 28, 2025
4 Insider transaction Jul 18, 2025 Jul 16, 2025
4 Insider transaction Jul 18, 2025 Jul 16, 2025
4 Insider transaction Jul 18, 2025 Jul 16, 2025
8-K Current report
Shareholder vote results
Jul 18, 2025 Jul 16, 2025
EFFECT Filing Jun 6, 2025 —
424B3 Prospectus Jun 6, 2025 —
DEFA14A Additional proxy material Jun 5, 2025 —
ARS Annual report to shareholders Jun 5, 2025 May 29, 2025
DEF 14A Proxy statement Jun 5, 2025 Jun 5, 2025
CORRESP Letter to the SEC Jun 4, 2025 —
UPLOAD Letter from the SEC Jun 4, 2025 —
S-8 Employee stock plan registration May 30, 2025 —
S-3 Shelf registration May 30, 2025 —
UPLOAD Letter from the SEC May 23, 2025 —
3 Initial insider ownership May 20, 2025 May 8, 2025
CORRESP Letter to the SEC May 20, 2025 —
PRE 14A Preliminary proxy statement May 14, 2025 May 14, 2025
10-Q Quarterly report May 9, 2025 Mar 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
May 9, 2025 May 9, 2025
UPLOAD Letter from the SEC May 6, 2025 —
4 Insider transaction Apr 30, 2025 Apr 28, 2025
4 Insider transaction Apr 3, 2025 Apr 1, 2025
SCHEDULE 13G Ownership over 5% (passive) Apr 2, 2025 —
10-K Annual report Mar 28, 2025 Dec 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Mar 28, 2025 Mar 28, 2025
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Mar 17, 2025 Mar 16, 2025
4 Insider transaction Jan 17, 2025 Jan 15, 2025
4 Insider transaction Jan 17, 2025 Jan 15, 2025
4 Insider transaction Jan 17, 2025 Jan 15, 2025
4 Insider transaction Jan 17, 2025 Jan 15, 2025
4 Insider transaction Jan 17, 2025 Jan 15, 2025
8-K Current report Jan 10, 2025 Jan 10, 2025
424B5 Prospectus supplement Jan 10, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Jan 6, 2025 —
8-K/A Amended current report
Shareholder vote results
Dec 20, 2024 Jul 31, 2024
3 Initial insider ownership Nov 20, 2024 Nov 14, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 20, 2024 —
10-Q Quarterly report Nov 8, 2024 Sep 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Nov 8, 2024 Nov 8, 2024
4 Insider transaction Oct 4, 2024 Oct 2, 2024
4 Insider transaction Oct 4, 2024 Oct 2, 2024
4 Insider transaction Oct 4, 2024 Oct 2, 2024
4 Insider transaction Oct 4, 2024 Oct 2, 2024
4 Insider transaction Oct 4, 2024 Oct 2, 2024
4 Insider transaction Aug 29, 2024 Aug 27, 2024
4 Insider transaction Aug 29, 2024 Aug 27, 2024
4 Insider transaction Aug 29, 2024 Aug 27, 2024
4 Insider transaction Aug 29, 2024 Aug 27, 2024
4 Insider transaction Aug 29, 2024 Aug 27, 2024
SC 13G/A Amended ownership over 5% (passive) Aug 20, 2024 —
S-8 Employee stock plan registration Aug 9, 2024 —
10-Q Quarterly report Aug 9, 2024 Jun 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Aug 9, 2024 Aug 9, 2024
8-K Current report
Shareholder vote results
Aug 2, 2024 Jul 31, 2024
4/A Filing Aug 2, 2024 Apr 19, 2024
4 Insider transaction Aug 2, 2024 Jul 31, 2024
DEFA14A Additional proxy material Jun 20, 2024 —
ARS Annual report to shareholders Jun 20, 2024 Jun 20, 2024
DEF 14A Proxy statement Jun 20, 2024 Jun 20, 2024
3 Initial insider ownership Jun 7, 2024 May 28, 2024
PRE 14A Preliminary proxy statement May 29, 2024 May 29, 2024
10-Q Quarterly report May 10, 2024 Mar 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
May 10, 2024 May 10, 2024
4 Insider transaction Apr 23, 2024 Apr 19, 2024
4 Insider transaction Apr 23, 2024 Apr 19, 2024
S-8 Employee stock plan registration Mar 8, 2024 —
10-K Annual report Mar 8, 2024 Dec 31, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Mar 8, 2024 Mar 8, 2024
8-K Current report
Regulation FD disclosure
Mar 4, 2024 Mar 4, 2024
424B3 Prospectus Feb 15, 2024 —
EFFECT Filing Feb 14, 2024 —
CORRESP Letter to the SEC Feb 14, 2024 —
S-3/A Filing Feb 14, 2024 —
8-K Current report
Regulation FD disclosure
Feb 2, 2024 Feb 2, 2024
S-3 Shelf registration Feb 2, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jan 16, 2024 —
4 Insider transaction Jan 16, 2024 Jan 12, 2024
4 Insider transaction Jan 11, 2024 Jan 10, 2024
4 Insider transaction Jan 3, 2024 Jan 1, 2024
4 Insider transaction Jan 3, 2024 Jan 1, 2024
4 Insider transaction Jan 3, 2024 Jan 1, 2024
4 Insider transaction Jan 3, 2024 Jan 1, 2024
4 Insider transaction Jan 3, 2024 Jan 1, 2024
4 Insider transaction Jan 3, 2024 Jan 1, 2024
4 Insider transaction Jan 3, 2024 Jan 1, 2024
8-K Current report
Other events
Jan 3, 2024 Jan 3, 2024
D Filing Jan 2, 2024 —
4 Insider transaction Dec 27, 2023 Dec 22, 2023
4 Insider transaction Dec 27, 2023 Dec 22, 2023
8-K Current report
Material agreement, Unregistered share sale
Dec 26, 2023 Dec 20, 2023
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Nov 14, 2023 Nov 14, 2023
4 Insider transaction Sep 14, 2023 Sep 13, 2023
4 Insider transaction Sep 14, 2023 Sep 13, 2023
8-K Current report
Shareholder vote results
Sep 13, 2023 Sep 13, 2023
4 Insider transaction Aug 24, 2023 Aug 22, 2023
3 Initial insider ownership Aug 24, 2023 Jun 4, 2023
4 Insider transaction Aug 23, 2023 Aug 21, 2023
4 Insider transaction Aug 22, 2023 Aug 21, 2023
ARS Annual report to shareholders Aug 16, 2023 Aug 15, 2023
DEF 14A Proxy statement Aug 15, 2023 Aug 15, 2023
10-Q Quarterly report Aug 11, 2023 Jun 30, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Aug 11, 2023 Aug 11, 2023
PRER14A Filing Jul 28, 2023 —
8-K Current report
Listing notice
Jun 30, 2023 Jun 29, 2023
25-NSE/A Filing Jun 29, 2023 —
8-K Current report
Other events
Jun 27, 2023 Jun 27, 2023
PRE 14A Preliminary proxy statement Jun 23, 2023 Jun 23, 2023
8-K Current report
Officer or director change
Jun 7, 2023 Jun 4, 2023
S-8 Employee stock plan registration Jun 2, 2023 —
10-Q Quarterly report May 5, 2023 Mar 31, 2023
8-K Current report
Results of operations, Regulation FD disclosure
May 5, 2023 May 5, 2023
4 Insider transaction Apr 25, 2023 Apr 24, 2023
4 Insider transaction Apr 25, 2023 Apr 24, 2023
4 Insider transaction Apr 25, 2023 Apr 24, 2023
4 Insider transaction Apr 6, 2023 Apr 4, 2023
10-K Annual report Mar 31, 2023 Dec 31, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Mar 31, 2023 Mar 31, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
4 Insider transaction Jan 4, 2023 Jan 2, 2023
4 Insider transaction Jan 4, 2023 Jan 2, 2023
4 Insider transaction Jan 4, 2023 Jan 2, 2023
4 Insider transaction Jan 4, 2023 Jan 2, 2023
4 Insider transaction Jan 4, 2023 Jan 2, 2023
4 Insider transaction Jan 4, 2023 Jan 2, 2023
8-K Current report
Listing notice
Nov 23, 2022 Nov 21, 2022
SC 13G/A Amended ownership over 5% (passive) Nov 18, 2022 —
SC 13G/A Amended ownership over 5% (passive) Nov 18, 2022 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
ENTX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Israel
Headquarters
Jerusalem
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1638097

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.